Plasma biomarkers for monitoring brain pathophysiology in FMR1 premutation carriers
Premutation carriers have a 55-200 CGG expansion in the fragile X mental retardation 1 (FMR1) gene. Currently, 1.5 million individuals are affected in the United States, and carriers are at risk of developing the late-onset neurodegenerative disorder Fragile X-associated tremor ataxia syndrome (FXTA...
Main Authors: | Cecilia Giulivi, Eleonora Napoli, Flora Tassone, Julian Halmai, Randi Hagerman |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-08-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnmol.2016.00071/full |
Similar Items
-
Impact of FMR1 Premutation on Neurobehavior and Bioenergetics in Young Monozygotic Twins
by: Eleonora Napoli, et al.
Published: (2018-08-01) -
Case Series: Vestibular Migraines in Fragile X Premutation Carriers
by: YeEun Tak, et al.
Published: (2024-01-01) -
Developmental aspects of FXAND in a man with the FMR1 premutation
by: Ellery Santos, et al.
Published: (2020-02-01) -
Neuropsychological changes in FMR1 premutation carriers and onset of fragile X-associated tremor/ataxia syndrome
by: Jessica Famula, et al.
Published: (2022-03-01) -
Premutation in the Fragile X Mental Retardation 1 (FMR1) Gene Affects Maternal Zn-milk and Perinatal Brain Bioenergetics and Scaffolding
by: Eleonora eNapoli, et al.
Published: (2016-04-01)